A detailed history of Tru North Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tru North Capital Management, LLC holds 1,300 shares of ABT stock, worth $150,670. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,300
Previous 1,300 -0.0%
Holding current value
$150,670
Previous $135 Million 9.72%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$100.73 - $112.44 $125,912 - $140,550
1,250 Added 2500.0%
1,300 $135 Million
Q1 2024

Jun 17, 2024

BUY
$109.52 - $120.96 $5,476 - $6,048
50 New
50 $5.68 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tru North Capital Management, LLC Portfolio

Follow Tru North Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru North Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru North Capital Management, LLC with notifications on news.